参考文献
-
1) HSPB1 suppresses oxLDL-induced vascular smooth muscle cell ferroptosis by inhibiting DPP4.
-
2) JS-K induces ferroptosis in renal carcinoma cells by regulating the c-Myc-GSTP1 Axis.
-
3) ZFP36 regulates the osteogenic differentiation of adipose-derived mesenchymal stem cells in osteoporosis by mediating KLF3 mRNA degradation.
-
4) Comprehensive analysis of LRRC42 as a potential biomarker and key cellular processes in cancer development.
-
5) Pulmonary Vascular Remodeling in Pulmonary Hypertension Mice Aggravated by Hypothyroidism.
-
6) A network pharmacology approach confirms Biejiaxiaozheng pills combat hepatic fibrosis by modulating macrophage inflammation and hepatic stellate cell activation.
-
7) ZDHHC9 promotes osteosarcoma progression via KRAS-associated enhancement of the RAS/MAPK signaling pathway.
-
8) IGF-1R promotes pain-like behavior in rats with myofascial pain syndrome via the PI3K/AKT pathway.
-
9) Arsenic trioxide regulates DYNAP through hsa-mir-573 and inhibits the proliferation of laryngeal cancer.
-
10) Naringin mitigates experimental autoimmune prostatitis by modulating oxidative stress and the NLRP3 inflammasome via the PPAR-γ/NF-κB pathway.
-
11) Role of Notch gene receptors as prognostic biomarkers in colorectal cancer.
-
12) Network pharmacology analyses and corresponding validation of the mechanistic effects of Yangyin Tongnao Granules in ischemic stroke.
-
13) Gentiopicroside improves DSS-induced ulcerative colitis and secondary liver injury in mice by enhancing the intestinal barrier and regulating the gut microbiome.
-
14) Exploring the anti-inflammatory mechanism of geniposide in rheumatoid arthritis via network pharmacology and experimental validation.
-
15) Exploration of the antitumor effect and mechanism of gambogic acid on osteosarcoma through network pharmacology and experimental pharmacology study.